|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Follow-up checks on liver alterations due to steroid contraceptives. |
| [Verlaufsuntersuchung uber Leberveranderungen infolge steroidaler |
| Bergmann M; Bode A; Hoffmann K |
| ZEITSCHRIFT FUR KLINISCHE MEDIZIN. 1991 Mar;46(7):505-7. |
| 987 women aged 18-45 were screened for ALAT, ASAT, and liver size to detect liver damage among users and |
| nonusers of oral contraceptives (OCs). 36 (3.6%) of them showed liver symptoms. 174 women of the same caseload |
| were examined in a follow-up; 57 dropped out. 116 women aged 19-50 remained, 54 nonusers and 62 OC users. 9 |
| women were classed as having liver disease, and 107 were classed as having healthy livers. In the whole sample, |
| daily consumption of alcohol averaged 2.9 + or - 3.2 gm. Side effects included spotting (50 cases), epigastric |
| complaints (10 cases), brown skin spots (3 cases), and migraine headache (18 cases). 2 OC users who had liver |
| symptoms had systolic blood pressure >180 mm Hg and diastolic pressure of 120 mm Hg. 38 women were also |
| taking other medication. Those with liver disease deviated more from the optimum body weight as measured by the |
| Mohr and Johnsen form. Healthy women had a liver size of 9.4 + or - 1.3 cm, while those with liver disease had a 10.3 |
| + or - 1.5 cm sized liver. 8 of the women with liver disease showed higher gamma-GT (glutamic transferase) activity |
| compared to healthy women. According to these findings, there is no connection between OC use and liver damage |
| as determined by aminotransferase activity. Therefore, the determination of ALAT activity for OC users is |
| superfluous, and it could save a lot money if this test were discontinued as presently practiced during the annual |
| gynecological examination of OC users. (PubHealth.info Document ID: CONT3T 2528-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Follow-up checks on liver alterations due to steroid |
| contraceptives. [Verlaufsuntersuchung uber Leberveranderungen infolge steroidaler Kontrazeptiva.]", is(are) |
| Bergmann M; Bode A; Hoffmann K. The source of this article is "ZEITSCHRIFT FUR KLINISCHE MEDIZIN. 1991 |
| Mar;46(7):505-7.". This article was published in 1991 in German language(s). (PubHealth.info® Document ID: |
| CONT3T 2528-06. All rights reserved with PubHealth.info) PIN: 12528 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
